West Pharmaceutical Names Michel Lagarde CEO
Published on 06/01/2026 at 10:21 pm BST
MT Newswires
|
Market Closed -
Other stock markets
|
After hours 01:00:00 | |||
| 527.05 USD | +0.45% |
|
495.82 | -5.93% |
![Robert Friel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert F. Friel is a businessperson who has been at the helm of 5 different companies. Presently, he holds the position of Independent Chairman of Xylem, Inc., Chairman-Supervisory Board for EUROIMMUN Medizinische Labordiagnostika AG and President for PerkinElmer Life & Analytical Sciences, Inc. He is also on the board of West Pharmaceutical Services, Inc., NuVasive, Inc., New York Life Insurance Co. and Analytical Life Science & Diagnostics Association. He previously was Chairman & Chief Executive Officer for PerkinElmer, Inc. (United States), President & Chief Executive Officer at Excelitas Technologies Sensors, Inc. and Treasurer & Vice President of Honeywell International LLC. Robert F. Friel received an undergraduate degree from Lafayette College and a graduate degree from Fairleigh Dickinson University.
Employees
125,000
Calendar
Trader
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
BBB
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
527.05USD
Average target price
590.77USD
Spread / Average Target
+12.09%
Quarterly revenue - Rate of surprise
- Stock Market
- Stock Market News
- West Pharmaceutical Names Michel Lagarde CEO
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
